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Heterocyclic fused α-methylene β-lactams were successfully
synthesized by a post-Ugi InIII-catalyzed intramolecular ad-
dition reaction. Switching from InCl3 to AlCl3 led to the re-
gioselective synthesis of α,β-unsaturated γ-lactams. More-
Introduction
2-Azetidinones, commonly known as β-lactams, are well-
established privileged scaffolds as proven by their wide-
spread applications in medicinal chemistry.[1] The core
structure of commonly used antibiotics such as penicillin,
aztreonam, nocardicin A, and the cholesterol lowering drug
ezetimibe is the β-lactam ring (Figure 1).[1,2] In addition, β-
lactams also serve as versatile building blocks for the syn-
thesis of various nitrogen-containing compounds such as
vitamins, alkaloids, and β-amino acids.[3] The classical route
for the construction of the β-lactam core is the Staudinger
reaction through the [2+2] cycloaddition of imines to
ketenes.[4] The generation of the latter requires treatment of
activated carboxylic acid derivatives such as acyl chlorides,
which sometimes lowers the synthetic utility. Considering
the vast pharmacological significance of the β-lactam
framework and the growing concern regarding bacterial re-
sistance, the development of new methodologies towards
the diversification of existing β-lactam antibiotics seems to
be imperative.[5] As a result, several new synthetic ap-
proaches have been developed,[6] with particular emphasis
on the generation of α-methylene β-lactams,[7] which are
versatile compounds delivering building blocks for the con-
struction of various β-lactam antibiotics[7c] (Scheme 1).
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over, replacing terminal alkynes by substituted alkynes in
the Ugi adducts resulted in the exclusive formation of γ-lact-
ams with both catalytic systems.
Figure 1. Examples of β-lactam-core-containing pharmaceuticals.
Over the last few decades, multicomponent reactions
(MCR)[8] and transition-metal-catalyzed[9] post-MCR
transformations have enabled easy access to complex het-
erocyclic scaffolds in a few steps.[10] Strategies for generating
β-lactams by employing β-amino acids[11] or β-keto acids[12]
as functionalized substrates in the Ugi reaction have also
been developed. Recently, bromoacetic acid[13] and phenyl-
propiolic acid[14] have been used to synthesize function-
alized β-lactams involving a sequential base-catalyzed tan-
dem Ugi reaction and intramolecular cyclization. Nonethe-
less, newer methodologies in terms of increased substrate
scope as well as starting material availability are always wel-
come. In continuation of our attempts towards the develop-
ment of diversity-oriented syntheses of various heterocyclic
scaffolds through post-Ugi transformations,[15] we envi-
sioned the synthesis of heterocyclic fused α-methylene β-
lactams by combination of a MCR with a metal-catalyzed
cascade cyclization. Herein, we report post-Ugi InIII-cata-
lyzed intramolecular nucleophilic cyclization for the synthe-
Job/Unit: O50270 /KAP1 Date: 07-05-15 12:33:49 Pages: 7
E. V. Van der Eycken et al.FULL PAPER
Scheme 1. Synthetic methods for α-methylene β-lactams; PMB =
p-methoxybenzyl, Ms = methylsulfonyl.
sis of N-heterocyclic fused α-methylene β-lactams. Interest-
ingly, switching from InIII to AlIII resulted in the generation
of another important class of N-heterocycles, that is, unsat-
urated γ-lactams, starting from the same Ugi adduct
(Scheme 1).
Results and Discussion
Initially, the Ugi four-component reaction (4-CR)[16] of
imidazo[1,2-a]pyridine-2-carbaldehyde (1a), p-methoxy-
benzylamine (2a), propiolic acid (3a), and cyclohexyl iso-
cyanide (4a) in methanol at room temperature generated
adduct 5a in 84% yield, which was selected to optimize the
reaction conditions of the next step. In continuation of our
previous success with gold and silver catalysis for the acti-
vation of alkynes,[14] we began our studies by screening
these catalysts in 1,2-dichloroethane (DCE) at 120 °C for
12 h (Table 1, entries 1–3). However, none of the catalysts
was able to complete the reaction. Moreover, the selectivity
for desired α-methylene β-lactam 6a was not good. There-
fore, we turned our attention to InIII catalysts, as these have
recently emerged as dual activators for carbonyl com-
pounds as well as for terminal alkynes in various reac-
tions.[17] Delightedly, the application of 10 mol-% of InCl3
was able to complete the reaction, and desired exo-cyclized
α-methylene β-lactam 6a was isolated in 36% yield (Table 1,
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entry 4). Increasing the catalyst loading of InCl3 to 20 mol-
% led to isolation of 6a in 73% yield (Table 1, entry 5).
However, a further increase in the catalyst loading to
30 mol-% did not significantly enhance the outcome of the
reaction (Table 1, entry 6). A drastic reduction in yield and
selectivity was observed upon switching the catalyst to in-
dium(III) trifluoromethanesulfonate [In(OTf)3; Table 1, en-
try 7]. Changing the solvent to toluene gave a slightly im-
proved yield of 6a (Table 1, entry 8), whereas o-xylene and
MeCN produced reduced yields (Table 1, entries 9 and 10).
Increasing the catalyst loading to 30 mol-% in toluene deliv-
ered 6a in 88% yield (Table 1, entry 11). No further im-
provement in yield or selectivity was observed upon further
increasing the amount of catalyst (Table 1, entry 12) or re-
ducing the reaction time or temperature (Table 1, entries 13
and 14). We next attempted to develop a catalytic system
for the exclusive generation of endo-cyclized product, that
is, γ-lactam 7a, which was observed as a minor product in
almost every case. Interestingly, replacing InCl3 with the
readily available Lewis acids AlCl3 and ZnCl2 resulted in
the formation of γ-lactam 7a in yields of 75 and 61%,
respectively (Table 1, entries 15 and 16). However, with CuI
and K2CO3 only decomposition of Ugi adduct 5a was ob-
served (Table 1, entries 17 and 18).
Table 1. Optimization of the intramolecular addition.[a]
Entry Catalyst Solvent Time Temp. Conversion [%][b]
(mol-%) [h] [°C] (6a/7a)
1 AgOTf (10) DCE 12 120 90 (40:50)
2 AgSbF6 (10) DCE 12 120 78 (50:28)
3 AuCl (10) DCE 12 120 80 (35:45)
4 InCl3 (10) DCE 12 120 100 (36:18)[c]
5 InCl3 (20) DCE 12 120 100 (73:8)[c]
6 InCl3 (30) DCE 12 120 100 (74:6)[c]
7 In(OTf)3 (20) DCE 12 120 100 (40:10)[c]
8 InCl3 (20) toluene 12 120 100 (78:8)[c]
9 InCl3 (20) o-xylene 12 120 100 (68:12)[c]
10 InCl3 (20) MeCN 12 120 100 (72:28)
11 InCl3 (30) toluene 12 120 100 (88:4)[c]
12 InCl3 (40) toluene 12 120 100 (86:5)[c]
13 InCl3 (30) toluene 6 120 100 (64:5)[c]
14 InCl3 (30) toluene 12 100 100 (56:5)[c]
15 AlCl3 (10) DCE 12 120 100 (0:75)[c]
16 ZnCl2 (10) DCE 12 120 100 (13:61)[c]
17 CuI (10) DCE 12 120 n.d.[d]
18 K2CO3[e] DCE 12 120 n.d.[d]
[a] All reactions were run on a 0.1 mmol scale of 5a in the indicated
solvent (2 mL). Cy = cyclohexyl. [b] Conversion and ratio based on
analysis by 1H NMR spectroscopy. [c] Yield of isolated product.
[d] n.d.: not detected. [e] K2CO3: 1 equiv.
With the optimized conditions for the synthesis of β-lact-
ams in hand (Table 1, entry 11), we evaluated the scope and
limitations of this intramolecular addition by using a vari-
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ety of different Ugi adducts 5a–t (Table 2). The intramolec-
ular cyclization proceeded smoothly in most cases to give
α-methylene β-lactams 6a–t in moderate to good yields. A
variety of substituents in the Ugi adducts were well toler-
ated. Employing the standard conditions to Ugi adducts 5n/
5o and 5p/5q prepared from 1-trityl-1H-imidazole-4-carb-
aldehyde and 4-methylthiazole-2-carbaldehyde, respectively,
produced corresponding alkylidene-β-lactams 6n/6o and 6p/
6q in yields of 30/33 and 58/62%, respectively. However, in
the case of Ugi adduct 5r derived from imidazo[1,2-a]pyr-
idine-3-carbaldehyde, no conversion was observed. Simi-
larly, the failure of Ugi adduct 5s derived from benzalde-
hyde to form 6s manifests the necessity of employing a ni-
Table 2. Scope and limitations for β-lactam formation.[a]
[a] All reactions were run on a 0.3 mmol scale of 5 with InCl3
(30 mol-%) in toluene (2 mL) in a screw-capped vial at 120 °C for
12 h. 3,4-DMB = 3,4-dimethoxybenzyl.
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trogen-containing aromatic aldehyde in the Ugi reaction.
Moreover, it was necessary to ensure that the use of propi-
olic acid resulted in intramolecular anti-Michael addition,
as Ugi adduct 5r from 4-pentynoic acid failed to produce
the desired alkylidene-β-lactam.
Further, the applicability of this protocol for the prepara-
tion of γ-lactams from Ugi adducts (e.g., 5d, 5g, 5i, 5l, 5m,
and 5o) is shown in Table 3. Good to moderate yields were
obtained for Ugi adducts obtained from various substituted
imidazo[1,2-a]pyridine-2-carbaldehydes (e.g., 7d, 7g, 7i, 7l,
and 7m). However, a low yield was noticed for the Ugi ad-
duct derived from 1-trityl-1H-imidazole-4-carbaldehyde
(i.e., 7o, Table 3). In addition, to scrutinize the necessity of
propiolic acid, Ugi adduct 8a was prepared from imid-
azo[1,2-a]pyridine-2-carbaldehyde by replacing propiolic
acid with 2-butynoic acid (3c), and it was subjected to the
Table 3. Scope and limitations for γ-lactam formation.[a]
[a] All reactions were run on a 0.3 mmol scale of 5 with AlCl3
(10 mol-%) in DCE (2 mL) in a screw-capped vial at 120 °C for
12 h.
Table 4. Scope and limitations for γ-lactam formation from substi-
tuted propargylamides.[a]
Product R1 R2 R3 R4 Yield [%]
9a tBu PMB Me H 72/69[b]
9b nBu piperonyl Me 6-Cl 99
9c tBu PMB Et H 77
9d tBu piperonyl Et 6-Cl 81
9e tBu 3,4-DMB Ph H 76
9f Cy PMB Ph 6-Me 82
[a] All reactions were run on a 0.3 mmol scale of 8 with InCl3
(10 mol-%) in DCE (2 mL) in a screw capped vial at 120 °C for
12 h. [b] AlCl3 (10 mol-%) was used.
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Scheme 2. Plausible reaction mechanism.
optimized conditions. However, instead of expected α-meth-
ylene β-lactam, γ-lactam 9a was observed as the only prod-
uct resulting from Michael addition (Table 4, entry 1). After
checking the influence of solvents, catalysts, and so on (see
the Supporting Information), the optimal conditions for
this Michael addition process were found to be 120 °C for
12 h in DCE as the solvent with InCl3 (10 mol-%) as the
catalyst. It is notable that employment of AlCl3 (10 mol-%)
gave γ-lactam 9a in 69% yield. The optimal process was
applied successfully to diversely substituted Ugi adducts
8b–f (see the Supporting Information) to deliver γ-lactams
9b–f in good to excellent yields. Remarkably, upon em-
ploying a bulky substituent such as a phenyl group on the
alkyne, no steric hindrance was observed, and compounds
9e and 9f were formed in yields of 76 and 82%, respectively.
On the basis of these observations and previous reports
on InIII,[17] we postulate a plausible mechanism for the nu-
cleophilic 4-exo-dig and 5-endo-dig additions (Scheme 2).
Moreover, preliminary DFT calculations were also per-
formed to understand the reaction mechanism and selectiv-
ity with the different substrates and Lewis acids (for details,
see the Supporting Information). In an initial step, we as-
sume that the Lewis acid coordinates to the substrate, which
thereby generates the enolate by deprotonation. Loss of a
chloride ion from the Lewis acid leads to neutral enolate A,
in which the alkyne group is coordinated to the metal cen-
ter. Transition states for 4-exo-dig and 5-endo-dig ring
closure have been located for R3 = H and Me, and for M =
Al and In, all of which lie 8–21 kcalmol–1 above the enolate.
www.eurjoc.org © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 0000, 0–04
Considering the likely computational errors, the relative en-
ergies of these transition states are in good agreement with
experimentally observed ring-closure selectivities: the for-
mation of the four-membered ring is predicted to be more
favorable in the case of R3 = H and M = In (ΔΔE‡ =
3.4 kcalmol–1), whereas the barriers for five-membered ring
formation are lower in all other cases (e.g., ΔΔE‡ =
–7.5 kcalmol–1 in the case of R3 = H, M = In). The prod-
ucts of these steps are vinyl–metal species that should un-
dergo facile protonolysis of the C–M bonds. Partial atomic
charge calculations (see the Supporting Information) sug-
gest that the relative electrophilicity of the two acetylenic
carbon atoms and thereby the selectivity is tuned by the R3
substituent and coordination to the metal.
Conclusions
In summary, we elaborated a diversity-oriented post-Ugi
intramolecular approach for the synthesis of α-methylene
β-lactams and α,β-unsaturated γ-lactams by employing Ugi
adducts with terminal and substituted alkynes. The diver-
sity of the desired products is guaranteed by the first step,
the Ugi 4-component reaction. The operational simplicity
together with the synthetic efficiency of the protocol will
facilitate the development of new antibiotics for countering
bacterial resistance. The biological activity of the generated
compounds is under current investigation.
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Experimental Section
General Procedure for the Synthesis of Ugi Products 5 and 8:
Na2SO4 (0.3 g), amine 2 (1.2 equiv.), acid 3 (1.2 equiv.), and iso-
cyanide 4 (1.2 equiv.) were added successively to a solution of carb-
aldehyde 1 (200 mg, 1 equiv.) in methanol (3 mL) in a screw-capped
vial equipped with a magnetic stir bar. The mixture was stirred at
room temperature for 24–48 in the closed vial. Upon completion
of the reaction, the mixture was diluted with EtOAc (100 mL) and
was extracted with water (50 mL). The organic layer was washed
with brine (50 mL), dried with magnesium sulfate, and evaporated
under reduced pressure to obtain a residue, which was subjected to
column chromatography (silica gel, 1–5% MeOH in CH2Cl2) to
afford desired product 5 and 8 as a solid. Ugi products appear as
a mixture of two rotamers, so the 1H NMR and 13C NMR spectra
are not very characteristic.
General Procedure for the Synthesis of Alkylidene β-Lactams 6
thorough InCl3-Catalyzed anti-Michael Addition: A glass vial was
charged with InCl3 (30 mol-%) and dry toluene (2 mL). Ugi prod-
uct 5 (0.3 mmol) was added. The mixture was stirred at 120 °C
until completion of the reaction. Upon completion, the mixture
was purified by column chromatography (silica gel, 1–3% MeOH
in CH2Cl2) to afford compound 6.
General Procedure for the Synthesis of γ-Lactams 7 thorough AlCl3-
Catalyzed Michael Addition: A glass vial was charged with AlCl3
(10 mol-%) and dry DCE (2 mL). Ugi product 5 (0.3 mmol) was
added. The mixture was stirred at 120 °C until completion of the
reaction. Upon completion, the mixture was purified by column
chromatography (silica gel, 1–3% MeOH in CH2Cl2) to afford
compound 7.
General Procedure for the Synthesis of γ-Lactams 9 thorough InCl3-
Catalyzed Michael Addition: A glass vial was charged with InCl3
(10 mol-%) and dry DCE (2 mL). Ugi product 8 (0.3 mmol) was
added. The mixture was stirred at 120 °C until completion of the
reaction. Upon completion, the mixture was purified by column
chromatography (silica gel, 1–3% MeOH in CH2Cl2) to afford
compound 9.
The products were characterized by 1H NMR and 13C NMR spec-
troscopy and HRMS, and the data were all in good agreement with
the assigned structures (for detailed experimental procedures and
data, see the Supporting Information).
General Procedure for DFT Calculations: Briefly, DFT calculations
were performed by using the B3LYP functional, the SVPP basis set
for all atoms other than In, and the SDD core potential and associ-
ated basis set for In in the Gaussian 09 program package.[18] Re-
ported energies include corrections for zero-point energy and dis-
persion [-D3(BJ) correction]. Full details of the computational pro-
tocol and additional results are in the Supporting Information.
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Diversity-Oriented Synthesis of β-Lactams
and γ-Lactams by Post-Ugi Nucleophilic
Cyclization: Lewis Acids as Regioselective
Switch
Keywords: Multicomponent reactions /
Nucleophilic cyclization / Regioselectivity /
Lewis acids / Lactams
A regioselective approach for the synthesis ploying a Ugi reaction followed by InIII- or
of heterocyclic fused α-methylene β-lact- AlIII-catalyzed intramolecular nucleophilic
ams and α,β-unsaturated γ-lactams by em- addition is reported.
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